Answers are grounded in this paper and cite their sources.
The paper highlights the revolutionary transformation and advancements in percutaneous structural and valvular heart disease interventions over the last decade.
The last decade has seen an enormous leap forward in the field of percutaneous structural heart disease interventions. We have witnessed a revolutionary transformation in our ability to treat valvular and structural heart disease and are now able to offer life-saving therapies to so many patients who had few good options previously.
No takes yet. Share an insight, caveat, or question.
Vavalle et al. (2020) conducted an editorial in Structural and valvular heart disease. Percutaneous structural and valvular heart disease interventions was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: